Skip to content

The Effect of 12 Lead ECG Telemetry on Reperfusion Time in Resource-limited Settings

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02441582
Enrollment
19
Registered
2015-05-12
Start date
2015-07-31
Completion date
2017-10-31
Last updated
2018-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction, STEMI

Brief summary

This study aims to determine whether prehospital 12 lead ECG telemetry decreases the time to reperfusion in patients presenting with STEMI. A randomised controlled trial will be conducted in Gauteng and the Western Cape among 100 adult patients (\>18 years) presenting with ST-elevation myocardial infarction according to a specific inclusion and exclusion criteria outlined in the full protocol. Consenting patients will be randomly assigned to have their prehospital ECG sent to the receiving cardiac facility or not. The onset-to-reperfusion and door-to-reperfusion times will be recorded and compared between the two groups by using the Fisher's exact test and a simple unpaired Student's t-test. Data will also be subjected to multivariate analysis of variance to test for statistical significance within a variety of factors that may influence reperfusion times.

Interventions

OTHERNon-telemetry

Sponsors

ER24
CollaboratorUNKNOWN
University of Stellenbosch
CollaboratorOTHER
Philips Healthcare
CollaboratorINDUSTRY
Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients (\> 18 years of age) * Patients presenting within the Gauteng or Western Cape areas * Current chest pain or dyspnoea, presumed to be of cardiac origin * ST-elevation (STEMI) on the ECG (defined as ST-elevation of 0.1 mV in two or more contiguous leads).

Exclusion criteria

* Non-adult patients * Chest pain of non-cardiac aetiology (following trauma or due to a primary respiratory pathology) * Non-consent to inclusion within the study * Patients without medical aid or who states that they cannot afford private healthcare. * Non-ST-elevation myocardial infarction

Design outcomes

Primary

MeasureTime frameDescription
Reperfusion TimeAt the first moment of reperfusion, from the date of randomisation up to 14 daysThis outcome measures the time it takes to reperfuse a coronary artery in STEMI

Secondary

MeasureTime frameDescription
Prehospital TimeOn arrival at hospital; from the time of randomisation up to six hoursThe prehospital time is the total time from arrival at the patient to arrival at the hospital
Onset to reperfusion timeAt the first moment of reperfusion, from the date of randomisation up to 14 daysThis pertains to the time it takes from the moment of first onset of symptoms to the first moment of reperfusion

Countries

South Africa

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026